Survey of adherence to treatment in inflammatory bowel disease. ENADEII study
| Autor: | Inmaculada Alonso-Abreu, Javier P. Gisbert, Marta Carrillo-Palau, María Chaparro, Alejandro Jiménez, Pilar Nos, Laura Ramos-López, Onofre Alarcón-Fernández, Enrique Quintero-Carrión |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Adult Male medicine.medical_specialty Disease Treatment results Inflammatory bowel disease Biological drugs 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans Medical treatment business.industry Gastroenterology Middle Aged University hospital medicine.disease Inflammatory Bowel Diseases Ulcerative colitis digestive system diseases 030104 developmental biology Physician gender Health Care Surveys Patient Compliance 030211 gastroenterology & hepatology Female business |
| Zdroj: | Gastroenterologia y hepatologia. 43(6) |
| ISSN: | 0210-5705 |
| Popis: | The rate of non-adherence to medical treatment in inflammatory bowel disease (IBD) is around 50%, with the consequent negative impact on treatment results, morbidity and cost. Objectives To determine through an online survey among gastroenterologists with special dedication to IBD, their knowledge about the adherence to treatment of their patients and the methods used to improve it. Methods An email was sent to gastroenterologists from the technical office of the Crohn's disease and ulcerative colitis Spanish working group (GETECCU), with a link to the online survey. Results 760 physicians were invited. One hundred eighty-four surveys were obtained (28.5%). A total of 68% of respondents had indexed IBD publications, 13% of which were on adherence. Although almost 99% considered adherence as very important/important, 25% of physicians did not assess it. Even though 100% considered that improving adherence would imply a better prognosis, 47% did not use any system to improve it. The factors associated with the assessment and improvement of adherence were: university hospital (81.4%), combined treatment with thiopurines and biological drugs (44.6%), physician gender (female) (63.1%), dedicating ≥6 h weekly to IBD (71.6%), previous published indexed papers on IBD (68.5%) and on adherence in IBD (12.5%), and considering adherence as important/very important (98.9%). Conclusions Although knowledge about the relevance of adherence to medical treatment in IBD is widespread, among the gastroenterologists with special dedication to IBD who were surveyed, almost half do not use any objective system to quantify it. An effort must be made to quantify and improve adherence to the treatment of these patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|